USPTO serial 97610635
-HDC
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- WANG, ASHLEY
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with -HDC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anuj Desai
Anuj Desai ARNALL GOLDEN GREGORY LLP171 17TH ST NWSUITE 2100ATLANTA, GA 30363Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Recorded computer programs for integration of patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems to support and interface with cloud-based software as a service (SAAS) services; Recorded medical software for integration of patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems to support and interface with cloud-based software as a service (SAAS) services | ACTIVE | — |
| 042 | Application service provider (ASP) featuring software using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Providing a website featuring non-downloadable software using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Providing on-line non-downloadable software using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Software as a service (SAAS) services, namely, hosting software for use by others for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events; Software as a service (SAAS) services featuring software using artificial intelligence for conducting health and individual patient risk assessments, providing adaptive nudges in clinical decision points, providing outcomes-based health care, prediction of health outcomes, improvement of health outcomes, providing decision support at clinical decision points, providing prescriptive analytics, providing patient data analytics, identifying risks and improving outcomes at point of care using integrated patient electronic health records (EHR) data, patient outcomes registries data, healthcare utilization databases, or data from healthcare financial systems, reducing cost of care, increasing provider reimbursement, standardizing healthcare services within an organization, tracking return on clinical investments, reducing probability of adverse events | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by tauSpan Technologies, LLC
- Other trademarks owned by tauSpan Technologies, LLC
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named -HDC
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 11, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 11, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 11, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 10, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 10, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 10, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 11, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 11, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 10, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 10, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 10, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 10, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 10, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 10, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 11, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 10, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 10, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 10, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 10, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 15, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 15, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 26, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 13, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 11, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 15, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2022 | NWAP | NEW APPLICATION ENTERED | — |